diltiazem has been researched along with hydrochlorothiazide in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (28.00) | 18.7374 |
1990's | 14 (28.00) | 18.2507 |
2000's | 10 (20.00) | 29.6817 |
2010's | 11 (22.00) | 24.3611 |
2020's | 1 (2.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Akamatsu, M | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Djian, J; Forette, B; Lekieffre, J; Luccioni, R; Roy, M | 1 |
Boulet, AP; Chockalingam, A; Fodor, JG; Houde, M; Laplante, L; Lenis, J; Logan, AG; Robitaille, MN; Ryan, D; Spénard, J | 1 |
Abraham, AS; Barchilon, E; Brooks, BA; Eylath, U; Grafstein, Y; Nubani, N; Shemesh, O | 1 |
Chalmers, J; Taylor, S; Wing, L | 1 |
Burris, JF; Cady, WJ; Oparil, S; Stewart, WH; Weber, M; Weir, MR | 1 |
Swartz, SL | 1 |
Gonzales, A; Kawanishi, DT; O'Rourke, RA; Rahimtoola, SH; Reid, CL | 1 |
Hartman, E; Leehey, DJ | 1 |
Fonteles, MC; Gadelha, MG; Menezes, AM; Rao, VS | 1 |
Anderson, M; Bartels, D; Eidelson, BA; Labreche, DG; MacCarthy, EP; Massie, B; Ramanathan, KB; Tubau, JF; Ulep, D; Weiss, RJ | 1 |
Horning, J; McClung, DE; McNulty, R; Simmons, J; TerWee, JA; Thomas, M; Williams, L; Zawada, ET | 1 |
Leary, WP; van der Byl, K | 1 |
Frishman, WH; Kirkendall, W; Lunn, J; McCarron, D; Moser, M; Schnaper, H; Smith, LK; Sowers, J; Swartz, SL; Zawada, ET | 1 |
Klein, MD; Weiner, DA | 1 |
Mohanty, PK; Sowers, JR; Thames, MD | 1 |
Frishman, WH; Kirkendall, W; Lunn, J; McCarron, D; Moser, M; Schnaper, H; Smith, LK; Sowers, J; Swartz, S; Zawada, E | 1 |
Lunn, J; Materson, BJ; Moser, M | 1 |
Benowitz, N; Inouye, IK; Loge, D; Massie, BM; Simpson, P | 1 |
Inouye, IK; Loge, D; Massie, BM; Simpson, P; Tubau, JF | 1 |
Kokkinos, P; Narayan, P; Papademetriou, V | 1 |
Anzalone, D; Chrysant, S; Fagan, T; Flamenbaum, W; Kaihlanen, PM; Lueg, M; Weir, MR | 1 |
Cushman, WC; Freis, ED; Fye, C; Gottdiener, J; Hamburger, RJ; Kochar, MS; Lakshman, R; Massie, BM; Materson, BJ; Reda, DJ | 1 |
Stewart, WH | 1 |
Joy, A; Manning, G; Mathias, CJ; McDonald, CJ; Millar-Craig, MW | 1 |
Anderson, RJ; Gottdiener, JS; Massie, BM; Materson, BJ; Reda, DJ; Williams, DW | 1 |
Cappuccio, FP; MacGregor, GA | 1 |
Dimmitt, DC; Geising, DH; Lanman, RC; Morrill, MB; Weir, SJ | 1 |
Cushman, WC; Freis, ED; Lakshman, MR; Materson, BJ; Reda, DJ | 1 |
Cushman, WC; Materson, BJ; Reda, DJ; Williams, DW | 1 |
Leenen, FH; Ruzicka, M | 1 |
Chen, CC; Dahly-Vernon, AJ; Dunn, KM; Ledbetter, SR; Murphy, SR; Roman, RJ; Williams, JM | 1 |
Asare-Addo, K; Boateng, J; Conway, BR; Larhrib, H; Levina, M; Nokhodchi, A; Rajabi-Siahboomi, AR; Tetteh, J | 1 |
Curtin, CR; Ford, L; Heald, D; Manitpisitkul, P; Shalayda, K; Wang, SS | 1 |
Kelemen, A; Kónya, Z; Pintye-Hódi, K; Regdon, G; Sipos, B; Sovány, T | 1 |
Aboul-Enein, HY; Ali, I; ALOthman, ZA; Alsheetan, KM | 1 |
3 review(s) available for diltiazem and hydrochlorothiazide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment of angina pectoris and hypertension with sustained-release calcium channel-blocking drugs.
Topics: Angina Pectoris; Biological Availability; Calcium Channel Blockers; Delayed-Action Preparations; Diltiazem; Drug Evaluation; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Verapamil | 1987 |
Combination therapy as first-line treatment of arterial hypertension.
Topics: Antihypertensive Agents; Atenolol; Captopril; Diltiazem; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Prazosin; Treatment Outcome | 2002 |
23 trial(s) available for diltiazem and hydrochlorothiazide
Article | Year |
---|---|
Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly.
Topics: Aged; Aging; Blood Pressure; Delayed-Action Preparations; Diltiazem; Drug Tolerance; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Triamterene | 1990 |
Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Diltiazem; Diuretics; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Single-Blind Method; Time Factors; Triamterene | 1991 |
Effects of hydrochlorothiazide, diltiazem and enalapril on mononuclear cell sodium and magnesium levels in systemic hypertension.
Topics: Aged; Diltiazem; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Leukocytes, Mononuclear; Magnesium; Male; Sodium; Water-Electrolyte Balance | 1991 |
Analysis of time trends, individual subject responses and background variation in crossover factorial studies with antihypertensive drugs.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension | 1990 |
An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy.
Topics: Adult; Analysis of Variance; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design | 1990 |
Endocrine and vascular responses in hypertensive patients to long-term treatment with diltiazem.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Body Weight; Diltiazem; Dinoprostone; Endocrine Glands; Female; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prostaglandins E; Pulse; Renin | 1987 |
Comparison of diltiazem and hydrochlorothiazide for treatment of patients 60 years of age or older with systemic hypertension.
Topics: Aged; Blood Pressure; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Electrocardiography; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Placebos; Potassium; Random Allocation | 1988 |
Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.
Topics: Adult; Age Factors; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol; Random Allocation | 1987 |
Renal-metabolic consequences of antihypertensive therapy with diltiazem versus hydrochlorothiazide.
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Electrolytes; Humans; Hydrochlorothiazide; Kidney; Middle Aged; Random Allocation; Renin | 1987 |
Diltiazem compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
Topics: Adult; Aged; Blood Pressure; Diltiazem; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pulse; Time Factors | 1988 |
Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
Topics: Adult; Age Factors; Clinical Trials as Topic; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; Potassium; Random Allocation | 1987 |
Effects of hydrochlorothiazide and diltiazem on reflex vasoconstriction in hypertension.
Topics: Adult; Blood Pressure; Diltiazem; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lower Body Negative Pressure; Male; Middle Aged; Random Allocation; Renin-Angiotensin System; Vascular Resistance; Vasoconstriction | 1987 |
Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem.
Topics: Aged; Benzazepines; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Diltiazem; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Random Allocation; Time Factors | 1985 |
Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension.
Topics: Adult; Aged; Benzazepines; Black or African American; Blood Pressure; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Random Allocation; Time Factors | 1985 |
Effects of diltiazem, metoprolol, enalapril and hydrochlorothiazide on frequency of ventricular premature complexes.
Topics: Analysis of Variance; Antihypertensive Agents; Cardiac Complexes, Premature; Diltiazem; Echocardiography; Electrocardiography, Ambulatory; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Metoprolol; Regression Analysis | 1994 |
Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension.
Topics: Blood Pressure; Diltiazem; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged | 1994 |
Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Age Factors; Aged; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Captopril; Clonidine; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin | 1993 |
Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension.
Topics: Adolescent; Adult; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Diastole; Diltiazem; Diuretics; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Sodium Chloride Symporter Inhibitors; Supine Position; Systole | 1996 |
Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Captopril; Clonidine; Cohort Studies; Diltiazem; Diuretics; Double-Blind Method; Echocardiography; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardium; Organ Size; Prazosin; Prevalence; Risk Factors; Sodium Chloride Symporter Inhibitors; Treatment Outcome; United States; United States Department of Veterans Affairs | 1997 |
Steady-state pharmacokinetics of diltiazem and hydrochlorothiazide administered alone and in combination.
Topics: Adult; Antihypertensive Agents; Area Under Curve; Calcium Channel Blockers; Cross-Over Studies; Diltiazem; Diuretics; Drug Combinations; Drug Interactions; Half-Life; Humans; Hydrochlorothiazide; Male; Sodium Chloride Symporter Inhibitors | 1998 |
Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Clonidine; Diltiazem; Diuretics; Double-Blind Method; Hospitals, Veterans; Humans; Hydrochlorothiazide; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Potassium; Prazosin; Time Factors; Treatment Outcome; United States | 1999 |
Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Clonidine; Diastole; Diltiazem; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin; Pressure; Pulse; Randomized Controlled Trials as Topic; Systole; Time Factors; Treatment Outcome | 2001 |
Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranolol.
Topics: Adolescent; Adult; Area Under Curve; Biotransformation; Diltiazem; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Fructose; Half-Life; Healthy Volunteers; Humans; Hydrochlorothiazide; Male; Metabolic Clearance Rate; Middle Aged; Propranolol; Topiramate; United States; Young Adult | 2014 |
24 other study(ies) available for diltiazem and hydrochlorothiazide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Delayed-Action Preparations; Diltiazem; Drug Therapy, Combination; Exercise Test; Female; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol | 1989 |
Effect of calcium-entry blockers on the diuretic response to hydrochlorothiazide in the rat.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Diuresis; Female; Hydrochlorothiazide; Nifedipine; Potassium; Rats; Rats, Inbred Strains; Sodium; Verapamil | 1988 |
Antihypertensive therapy with diltiazem and comparison with hydrochlorothiazide.
Topics: Aged; Benzazepines; Blood Pressure; Diltiazem; Epinephrine; Female; Heart Rate; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Norepinephrine; Posture; Renin | 1984 |
Failure of antihypertensive therapy with diuretic, beta-blocking and calcium channel-blocking drugs to consistently reverse left ventricular diastolic filling abnormalities.
Topics: Benzazepines; Blood Pressure; Cardiac Volume; Diltiazem; Female; Heart; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol; Radionuclide Imaging; Stroke Volume | 1984 |
Application of response surface methodology and factorial designs to clinical trials for drug combination development.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Data Interpretation, Statistical; Diltiazem; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Statistics as Topic | 1996 |
Lack of effect of a diuretic added to diltiazem.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Data Interpretation, Statistical; Diltiazem; Diuretics; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Research Design; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 1997 |
Renoprotective effects of anti-TGF-β antibody and antihypertensive therapies in Dahl S rats.
Topics: Acute Kidney Injury; Animals; Antibodies, Anti-Idiotypic; Antihypertensive Agents; Blood Pressure; Captopril; Diltiazem; Disease Models, Animal; Female; Fibrosis; Hydrochlorothiazide; Hypertension; Male; Proteinuria; Rats; Rats, Inbred Dahl; Sex Characteristics; Sodium Chloride, Dietary; Transforming Growth Factor beta | 2012 |
The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
Topics: Calorimetry, Differential Scanning; Delayed-Action Preparations; Diltiazem; Hydrochlorothiazide; Hydrogen-Ion Concentration; Hypromellose Derivatives; Osmolar Concentration; Solubility | 2013 |
Physicochemical characterisation and investigation of the bonding mechanisms of API-titanate nanotube composites as new drug carrier systems.
Topics: Atenolol; Calorimetry, Differential Scanning; Diclofenac; Diltiazem; Drug Carriers; Drug Liberation; Hydrochlorothiazide; Microscopy, Electron, Scanning; Nanotubes; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Thermogravimetry; Titanium | 2017 |
Applications of shun shell column and nanocomposite sorbent for analysis of eleven anti-hypertensive in human plasma.
Topics: Adsorption; Antihypertensive Agents; Chromatography, High Pressure Liquid; Diltiazem; Furosemide; Humans; Hydrochlorothiazide; Irbesartan; Iron; Labetalol; Limit of Detection; Losartan; Metal Nanoparticles; Methyldopa; Nanocomposites; Polyvinyl Alcohol; Prazosin; Propranolol; Reproducibility of Results; Solid Phase Microextraction; Spironolactone; Valsartan | 2020 |